Other Digestive System O.R. Procedures without CC/MCC DRG Reimbursement

DRG 358 encompasses other digestive system operating room procedures without a Major Complication or Comorbidity or a Complication or Comorbidity, covering lower-severity gastrointestinal and hepatobiliary surgeries. This grouping matters for inpatient reimbursement because it establishes the payment weight tied to expected resource use for these procedures under Medicare.

DRG 358 Overview

DRG 358 covers inpatient stays for other digestive system operating room procedures without a Major Complication or Comorbidity or a Complication or Comorbidity. It includes a range of gastrointestinal and hepatobiliary surgeries that are not categorized under higher-severity groups and typically reflect lower resource use. This Diagnosis-Related Group matters for Medicare payment because it helps determine hospital reimbursement based on the expected intensity of care for these procedures. Accurate clinical coding and documentation influence placement in this Diagnosis-Related Group and the associated payment.

Acute perioperative optimization and complication-prevention trials: randomized or pragmatic studies evaluating interventions to reduce intraoperative and immediate postoperative complications for patients undergoing non-routine digestive system operations (for example complex biliary, small bowel resection, or exploratory laparotomy procedures) without major comorbid complications. These trials enroll adult inpatients scheduled for operative procedures captured by this DRG and test protocols such as enhanced intraoperative monitoring bundles, fluid and hemodynamic strategies, or perioperative antibiotic stewardship to reduce surgical-site infections and reoperation rates. Results are directly relevant to hospitals and payers because reducing short-term complications can shorten length of stay and decrease costly readmissions tied to surgical morbidity in this DRG cohort.
Comparative effectiveness studies of surgical approaches and resource utilization: prospective or registry-based studies comparing different operative techniques (open versus minimally invasive approaches, varied anastomotic methods, or differing perioperative care pathways) for heterogeneous digestive procedures without major CC/MCC. These studies focus on adult patients whose index hospitalization falls under this DRG to evaluate outcomes such as operative time, blood loss, transfusion need, postoperative recovery metrics, discharge disposition, and total inpatient costs. Findings inform provider decision-making about procedure selection and pathway standardization and help payers assess value by linking technique choice to resource use and reimbursement implications.
Post-discharge outcomes and readmission risk stratification research: observational cohort or predictive-modeling studies that follow patients after discharge from index hospitalizations for other digestive system O.R. procedures to identify drivers of 30- and 90-day readmission, functional recovery, and post-acute care needs. These studies enroll the typical DRG population, including patients without major comorbid complications, to examine social determinants, discharge disposition (home versus skilled nursing), and early outpatient follow-up patterns that influence downstream utilization. The evidence guides care-management programs, transition-of-care interventions, and payer strategies to reduce preventable readmissions and optimize post-acute resource allocation for this surgical group.

Acute perioperative optimization and complication-prevention trials: randomized or pragmatic studies evaluating interventions to reduce intraoperative and immediate postoperative complications for patients undergoing non-routine digestive system operations (for example complex biliary, small bowel resection, or exploratory laparotomy procedures) without major comorbid complications. These trials enroll adult inpatients scheduled for operative procedures captured by this DRG and test protocols such as enhanced intraoperative monitoring bundles, fluid and hemodynamic strategies, or perioperative antibiotic stewardship to reduce surgical-site infections and reoperation rates. Results are directly relevant to hospitals and payers because reducing short-term complications can shorten length of stay and decrease costly readmissions tied to surgical morbidity in this DRG cohort.
Comparative effectiveness studies of surgical approaches and resource utilization: prospective or registry-based studies comparing different operative techniques (open versus minimally invasive approaches, varied anastomotic methods, or differing perioperative care pathways) for heterogeneous digestive procedures without major CC/MCC. These studies focus on adult patients whose index hospitalization falls under this DRG to evaluate outcomes such as operative time, blood loss, transfusion need, postoperative recovery metrics, discharge disposition, and total inpatient costs. Findings inform provider decision-making about procedure selection and pathway standardization and help payers assess value by linking technique choice to resource use and reimbursement implications.
Post-discharge outcomes and readmission risk stratification research: observational cohort or predictive-modeling studies that follow patients after discharge from index hospitalizations for other digestive system O.R. procedures to identify drivers of 30- and 90-day readmission, functional recovery, and post-acute care needs. These studies enroll the typical DRG population, including patients without major comorbid complications, to examine social determinants, discharge disposition (home versus skilled nursing), and early outpatient follow-up patterns that influence downstream utilization. The evidence guides care-management programs, transition-of-care interventions, and payer strategies to reduce preventable readmissions and optimize post-acute resource allocation for this surgical group.

OpenPayer

Summary & Overview

Other Digestive System O.R. Procedures without CC/MCC: Inpatient Reimbursement Overview

DRG 358 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes